- Home
- LBTYA vs ZLAB Comparison
LBTYA vs ZLAB Comparison
Compare LBTYA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYA
- ZLAB
- Stock Information
- Founded
- LBTYA 2004
- ZLAB 2013
- Country
- LBTYA Bermuda
- ZLAB China
- Employees
- LBTYA N/A
- ZLAB N/A
- Industry
- LBTYA Cable & Other Pay Television Services
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- LBTYA Telecommunications
- ZLAB Health Care
- Exchange
- LBTYA Nasdaq
- ZLAB Nasdaq
- Market Cap
- LBTYA 3.7B
- ZLAB 4.0B
- IPO Year
- LBTYA N/A
- ZLAB 2017
- Fundamental
- Price
- LBTYA $11.53
- ZLAB $35.73
- Analyst Decision
- LBTYA Buy
- ZLAB Buy
- Analyst Count
- LBTYA 5
- ZLAB 6
- Target Price
- LBTYA $14.96
- ZLAB $57.22
- AVG Volume (30 Days)
- LBTYA 2.2M
- ZLAB 755.3K
- Earning Date
- LBTYA 08-01-2025
- ZLAB 08-07-2025
- Dividend Yield
- LBTYA N/A
- ZLAB N/A
- EPS Growth
- LBTYA N/A
- ZLAB N/A
- EPS
- LBTYA N/A
- ZLAB N/A
- Revenue
- LBTYA $4,633,000,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- LBTYA $8.82
- ZLAB $45.16
- Revenue Next Year
- LBTYA $1.16
- ZLAB $56.81
- P/E Ratio
- LBTYA N/A
- ZLAB N/A
- Revenue Growth
- LBTYA 81.79
- ZLAB 32.56
- 52 Week Low
- LBTYA $9.03
- ZLAB $16.03
- 52 Week High
- LBTYA $21.56
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- LBTYA 74.57
- ZLAB 48.57
- Support Level
- LBTYA $10.81
- ZLAB $34.37
- Resistance Level
- LBTYA $11.14
- ZLAB $35.83
- Average True Range (ATR)
- LBTYA 0.36
- ZLAB 1.13
- MACD
- LBTYA 0.09
- ZLAB -0.32
- Stochastic Oscillator
- LBTYA 96.94
- ZLAB 31.88
About LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.